$284.57
-0.70 (-0.25%)
OSIS News14 articles
IRS Direct Deposit Snag Delays Refunds for Over 800,000 Taxpayers
The IRS has issued more than 830,000 notices to taxpayers with invalid direct deposit information, potentially delaying refunds by over 10 weeks. Lawmakers are questioning how unbanked individuals can access funds faster.
Brazilian Banks Gain as Central Bank Eases Liquidity Crunch from Deposit Insurance Prepayments
Brazil's central bank announced a measure allowing banks to offset mandatory prepayments to the deposit insurance fund against reserve requirements, potentially unlocking R$30 billion in liquidity by 2026. Shares of major Brazilian banks, including Banco Bradesco, rose following the news.
Santos' Beetaloo Fracking Plan Draws Scientific, Indigenous Opposition Over Hot Springs Risk
Santos' proposal to drill and frack 12 test wells in the Beetaloo Basin faces opposition from scientists and Indigenous custodians, who warn of threats to the ecologically sensitive Hot Springs Valley. The Northern Territory regulator is reviewing the environmental plan.
Major Funds Boost Apple Holdings in Q3, New Positions Emerge
Several investment firms, including Strategic Advisors LLC and AE Wealth Management, increased their holdings in Apple Inc. during the third quarter, with new positions also initiated. Apple shares traded at $264.18, giving the company a market capitalization of approximately $4.05 trillion.
Amazon's Nine-Day Slide Marks Longest Losing Streak in Nearly Two Decades
Amazon shares declined for a ninth straight day, marking their longest losing streak since 2006. The stock has retreated more than 20% from its November peak as investors scrutinize the company's massive AI spending plans.
Kraken Launches 3% Deposit Match, Capped at $30K Through March
Kraken is running a promotion matching 3% of new cash and crypto deposits, with rewards limited to $30,000 per account. The bonus comes with an 18-month holding requirement.
IRS Direct Deposit Errors Could Delay 2026 Tax Refunds, Agency Warns
The IRS cautions that incorrect bank details may freeze refunds this filing season, urging taxpayers to verify information and use electronic tools for faster processing.
Heineken to Slash Up to 6,000 Positions in Major Cost-Restructuring Drive
Heineken announces a global workforce reduction of 5,000-6,000 roles over two years, targeting €400-500 million in annual savings. The move comes amid softening beer demand and a pending CEO transition.
IRS Warns 2026 Tax Refund Delays Likely Without Accurate Direct Deposit Details
The IRS cautions that missing or incorrect bank information will hold 2026 refunds, with updates only accepted by mail. Most e-filed refunds arrive within 21 days, but delays could extend into March.
Phio Pharmaceuticals Shares Surge on Positive Skin Cancer Trial Data
Phio Pharmaceuticals stock climbed nearly 10% premarket following encouraging safety and efficacy results from a Phase 1b skin cancer study. The company targets an FDA submission in the second quarter of 2026.
LSEG Shares Surge as Elliott Management Takes Activist Position, Advocates for Buyback
London Stock Exchange Group's stock rose 4.7% to 7,714 pence following reports that activist investor Elliott Management has built a significant stake and is pushing for a new multibillion-pound share repurchase program and improved margins.
Boston Scientific Stock Rebounds on Positive Farapulse Data, CHAMPION-AF Trial Looms
Boston Scientific shares recovered slightly after a recent sell-off, supported by new long-term data for its Farapulse ablation system. Investor focus now shifts to the upcoming CHAMPION-AF trial results expected in late March.
Snowflake Shares Surge as Jefferies Defends AI Position, Calls Selloff Overdone
Snowflake stock climbed nearly 5% in extended trading after Jefferies reaffirmed its bullish stance, dismissing recent AI-related concerns as excessive. Investors now await key inflation data and the company's upcoming earnings report.
Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.